Naloxone

"Naloxone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors.

Descriptor ID	D009270
MeSH Number(s)	D03.132.577.249.706 D03.605.497.750 D03.633.400.686.750 D04.615.723.795.706
Concept/Terms	Naloxone Naloxone Nalone Nalone Naloxon Curamed Naloxon Curamed Curamed, Naloxon Naloxon-Ratiopharm Naloxon-Ratiopharm Naloxon Ratiopharm Naloxone Abello Naloxone Abello Abello, Naloxone Naloxone Hydrochloride Naloxone Hydrochloride Hydrochloride, Naloxone Naloxone Hydrochloride Dihydride Naloxone Hydrochloride Dihydride Dihydride, Naloxone Hydrochloride Hydrochloride Dihydride, Naloxone Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer Narcan Narcan Narcanti MRZ-2593 MRZ-2593 MRZ 2593 MRZ2593 MRZ 2593-Br MRZ 2593 Br MRZ 2593Br Naloxone Hydrobromide Naloxone Hydrobromide Hydrobromide, Naloxone

Below are MeSH descriptors whose meaning is more general than "Naloxone".

Chemicals and Drugs [D]
Heterocyclic Compounds [D03]
Alkaloids [D03.132]
Opiate Alkaloids [D03.132.577]
Morphinans [D03.132.577.249]
Naloxone [D03.132.577.249.706]
Heterocyclic Compounds, Bridged-Ring [D03.605]
Morphinans [D03.605.497]
Naloxone [D03.605.497.750]
Heterocyclic Compounds, Fused-Ring [D03.633]
Heterocyclic Compounds, 4 or More Rings [D03.633.400]
Morphinans [D03.633.400.686]
Naloxone [D03.633.400.686.750]
Polycyclic Compounds [D04]
Polycyclic Aromatic Hydrocarbons [D04.615]
Phenanthrenes [D04.615.723]
Morphinans [D04.615.723.795]
Naloxone [D04.615.723.795.706]

Below are MeSH descriptors whose meaning is related to "Naloxone".

Below are MeSH descriptors whose meaning is more specific than "Naloxone".

Naloxone
Buprenorphine, Naloxone Drug Combination
Naltrexone

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Naloxone" by people in this website by year, and whether "Naloxone" was a major or minor topic of these publications.

Bar chart showing 17 publications over 13 distinct years, with a maximum of 2 publications in 2016 and 2017 and 2021 and 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2003	0	1	1
2004	0	1	1
2005	0	1	1
2006	1	0	1
2012	1	0	1
2013	1	0	1
2015	1	0	1
2016	1	1	2
2017	0	2	2
2019	0	1	1
2021	1	1	2
2022	0	1	1
2023	0	2	2

Below are the most recent publications written about "Naloxone" by people in Profiles.

Kusic DM, Heil J, Zajic S, Brangan A, Dairo O, Heil S, Feigin G, Kacinko S, Buono RJ, Ferraro TN, Rafeq R, Haroz R, Baston K, Bodofsky E, Sabia M, Salzman M, Resch A, Madzo J, Scheinfeldt LB, Issa JJ, Jelinek J. Postmortem toxicology findings from the Camden Opioid Research Initiative. PLoS One. 2023; 18(11):e0292674.

View in: PubMed
Deutsch SA, De Jong AR. Xylazine Complicating Opioid Ingestions in Young Children. Pediatrics. 2023 01 01; 151(1).

View in: PubMed
Calello DP, Aldy K, Jefri M, Nguyen TT, Krotulski A, Logan B, Brent J, Wax P, Walton S, Manini AF. Identification of a novel opioid, N-piperidinyl etonitazene (etonitazepipne), in patients with suspected opioid overdose. Clin Toxicol (Phila). 2022 09; 60(9):1067-1069.

View in: PubMed
Krotulski AJ, Chapman BP, Marks SJ, Ontiveros ST, Devin-Holcombe K, Fogarty MF, Trieu H, Logan BK, Merchant RC, Babu KM. Sentanyl: a comparison of blood fentanyl concentrations and naloxone dosing after non-fatal overdose. Clin Toxicol (Phila). 2022 Feb; 60(2):197-204.

View in: PubMed
Stein BD, Jones CM, Smart R, Sheng F, Sorbero M. Patient, prescriber, and Community factors associated with filled naloxone prescriptions among patients receiving buprenorphine 2017-18. Drug Alcohol Depend. 2021 04 01; 221:108569.

View in: PubMed
Cannaert A, Deventer M, Fogarty M, Mohr ALA, Stove CP. Hide and Seek: Overcoming the Masking Effect of Opioid Antagonists in Activity-Based Screening Tests. Clin Chem. 2019 12; 65(12):1604-1605.

View in: PubMed
Griswold MK, Chai PR, Krotulski AJ, Friscia M, Chapman BP, Varma N, Boyer EW, Logan BK, Babu KM. A Novel Oral Fluid Assay (LC-QTOF-MS) for the Detection of Fentanyl and Clandestine Opioids in Oral Fluid After Reported Heroin Overdose. J Med Toxicol. 2017 Dec; 13(4):287-292.

View in: PubMed
Griswold MK, Chai PR, Krotulski AJ, Friscia M, Chapman B, Boyer EW, Logan BK, Babu KM. Self-identification of nonpharmaceutical fentanyl exposure following heroin overdose. Clin Toxicol (Phila). 2018 Jan; 56(1):37-42.

View in: PubMed
Sammon M, Dawood A, Beaudoin S, Harrigan RA. An Unusual Case of Alternating Ventricular Morphology on the 12-Lead Electrocardiogram. J Emerg Med. 2017 Mar; 52(3):348-353.

View in: PubMed
Eriksen GS, Andersen JM, Boix F, Bergh MS, Vindenes V, Rice KC, Huestis MA, M?rland J. Comparison of (+)- and (-)-Naloxone on the Acute Psychomotor-Stimulating Effects of Heroin, 6-Acetylmorphine, and Morphine in Mice. J Pharmacol Exp Ther. 2016 08; 358(2):209-15.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement